Head to head
Repligen vs Intuitive Surgical
Side-by-side on the measures that matter, with a plain-English read. Full detail: RGEN · ISRG
RGEN
Repligen
167.22-4.37%
1-year price shape — +15% over the period
Quant Rating C · 53/100
vs
ISRG
Intuitive Surgical
414.52+2.41%
1-year price shape — -6% over the period
Quant Rating D · 30/100
1-year performance, rebased to 100
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical trades cheapest on trailing earnings; Intuitive Surgical earns the most per share.
| RGEN | ISRG | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Instruments & Supplies | Medical Instruments & Supplies |
| Last price | 167.22 | 414.52 |
| Change today | -4.37% | +2.41% |
| 1-year return | +14.6% | -6.0% |
| Market cap | $10.62B | $146.44B |
| 52-week range | 100.99 – 198.87 | 328.57 – 603.88 |
| Valuation | ||
| P/E (TTM) | 229.07 | 47.54 |
| P/E percentile, own 5-yr range | 87th | 6th |
| P/B | 5.03 | 8.06 |
| Dividend yield | 0.00% | 0.00% |
| Profitability & growth | ||
| EPS (TTM) | 0.86 | 7.87 |
| Net profit (TTM) | $54.60M | $2.78B |
| Revenue (TTM) | $785.10M | $11.03B |
| Revenue growth (YoY) | +11.9% | +18.5% |
| Gross margin | 53.5% | 66.7% |
| Operating margin | 7.8% | 31.3% |
| Net margin | 5.3% | 28.4% |
| Free cash flow (TTM) | $110.15M | $3.22B |
| Ownership & sentiment | ||
| Institutional ownership | 123.1% | 88.8% |
| Insider activity (12mo) | 28 buy / 22 sell | 21 buy / 29 sell |
| Short interest (% of float) | 11.9% | 2.3% |
| Analyst consensus | 90% buy / 10% hold (10) | 86% buy / 14% hold (21) |
| Analyst price target | $184 (+10%) | $490 (+18%) |
| StockVane view | ||
| StockVane Quant Rating | C (53) | D (30) |
| Company | ||
| Employees | 2,000 | 17,021 |
| Founded | 1981 | 1995 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.